Hospitals and health system pharmacists urge FDA to take a closer look at ‘white bagging’

(Photo by Kathrin Ziegler/Getty Pictures) The observe known as “white bagging” is exacerbating provide chain…

(Photo by Kathrin Ziegler/Getty Pictures)

The observe known as “white bagging” is exacerbating provide chain safety troubles and jeopardizing affected individual safety, the American Modern society of Wellness-Technique Pharmacists and the American Healthcare facility Affiliation instructed performing Food and Drug commissioner Dr. Janet Woodcock in a March 31 letter.

ASHP and AHA strongly inspired the Food and drug administration to consider the affected individual safety and provide chain safety risks of white bagging, and get correct enforcement motion, in accordance to the March 31 letter sent by AHA government vice president Thomas P. Nickels and Tom Kraus, vice president of authorities relations for the American Modern society of Wellness-Technique Pharmacists.


At stake for hospitals is reimbursement.

White bagging is a strategy of shipping by which medical doctor-administered medicines are dispensed by a specialty pharmacy for a certain affected individual, transported to the medical doctor for administration and frequently paid out below the pharmacy advantage relatively than the professional medical advantage, in accordance to obroncololgy.

The specialty pharmacy is reimbursed by the payer for the drug, when the medical doctor is only paid out a drug administration charge.

ASHP and AHA stated payers are making use of white bagging to circumvent clinic provide chain controls by requiring affected individual prescription drugs be dispersed by a slim community of specialty pharmacies that are generally instantly affiliated with the payer. This disregards the Drug Offer Chain Security Act’s specifications for wholesale distribution of medicines, they stated. 

The Drug Offer Chain Security Act, enacted by Congress in 2013, outlines ways to make an electronic, interoperable method to establish and trace specified prescription medicines as they are dispersed in the United States, in accordance to the Food and drug administration.

THE More substantial Craze

White bagging has surged in frequency about the earlier 10 years, building what amounts to a shadow inventory that hospitals and wellness methods do not legally very own, and which exists largely outdoors of the Act’s observe-and-trace specifications, stated the AHA and ASHP,  which signifies pharmacists who provide as affected individual care suppliers in hospitals, wellness methods, ambulatory clinics and other healthcare options.  

A Drug Channels report discovered that in 2019, almost a third of infusion medicines presented in clinic outpatient departments had been dispersed by means of white bagging, in accordance to the companies. Offered the increasing use of payer-mandated white bagging, the ASHP and AHA stated they are concerned this observe threatens the Drug Offer Chain Security Act’s underlying plans. 

Additional, because hospitals do not have legal title to white-bagged prescription drugs, and the medicines are delivered outdoors of clinic-recognized provide chains, white bagging can elevate extra affected individual safety risks by enabling diversion and heightening the probability of drug spoilage and squander, they stated. 

In addition, due to the fact white-bagged medicines bypass recognized provide chain channels, they also disrupt and noticeably complicate the capability to respond to Food and drug administration drug remembers.

Twitter: @SusanJMorse
E-mail the writer: [email protected]